Mark S. Levine Flexion Therapeutics Inc (FLXN) insider trading activity

FLXN Quotes by TradingView

Mark S. Levine is General Counsel of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 133,486 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $1,134,631. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark S. Levine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Sale (or disposition) back to the issuer
$1,134,631 $8.5 p/Share
133,486 Reduced 100.0%
0 Common Stock
Jul 19 2021
SELL
Open market or private sale
$25,445 $6.45 p/Share
3,945 Reduced 2.87%
133,486 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 17.92%
137,431 Common Stock
Jan 05 2021
SELL
Open market or private sale
$76,007 $11.13 p/Share
6,829 Reduced 5.98%
107,431 Common Stock

Also insider at

IMVT
Immunovant, Inc. Healthcare
Chief Legal Officer
MSL

Mark S. Levine

General Counsel
New York, NY

Track Institutional and Insider Activities on FLXN

Follow Flexion Therapeutics Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLXN shares.

Notify only if

Insider Trading

Get notified when an Flexion Therapeutics Inc insider buys or sells FLXN shares.

Notify only if

News

Receive news related to Flexion Therapeutics Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FLXN